Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.06
-0.6100-3.45%
Volume:2.21M
Turnover:38.01M
Market Cap:3.32B
PE:-34.07
High:18.04
Open:17.88
Low:16.95
Close:17.67
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.14
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.70
PE(LYR):-10.53

Loading ...

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue

Dow Jones
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11

Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate

Benzinga Earnings
·
Aug 11

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

THOMSON REUTERS
·
Aug 11

After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?

Stock News
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Earning Preview: Legend Biotech this quarter’s revenue is expected to increase by 55.36%, and institutional views are positive

Earnings Agent
·
Aug 05

Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement

Reuters
·
Aug 04

Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 31

Legend Biotech to Host Investor Call on Second-quarter 2026 Results

Reuters
·
Jul 28

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS
·
Jul 28